Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Nov 23, 24
1 min read


iDose® TR marks a significant breakthrough in the treatment of glaucoma, providing a sustained and effective solution for managing intraocular pressure (IOP). Differing from traditional eye drops that need to be applied every day, iDose® TR is a small, implantable device designed to deliver a controlled dispensation of treatment directly into the eye over an longer period. This innovative approach reduces the burden of constant dosing, dramatically boosting patient adherence and overall treatment results.

At Eye Center South, we are honored to introduce iDose® TR as part of our all-encompassing glaucoma care. The device is placed during a gentle procedure, designed with your ease in mind. Once in place, it ensures a steady dose of the prescribed medication, keeping IOP levels consistent and protect your vision. Patients who struggle with the challenges of daily eye drop regimens can benefit greatly from this next-generation treatment.



Visit for more info At Eye Center South